CINCINNATI, Oct. 19 /PRNewswire-FirstCall/ -- Kendle International Inc. , a leading, global full-service clinical research organization, today announced the appointment of Jill Collard as Director, Biometrics - Europe. In this role, Collard has overall responsibility for the growth of Kendle’s Biometrics business in Europe, including the continued growth and development of the statistical, clinical data management and scientific programming services the company offers.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
“Jill will be a tremendous asset to Kendle as she combines significant CRO and pharmaceutical industry experience with expertise in clinical data operations supporting Phase I-IV clinical trials,” said Alan Boyce, Vice President, Europe.
Collard joins Kendle from Napp Pharmaceutical Research Ltd., where she served as Head of Clinical Data Operations & Systems, Europe. While at Napp she was responsible for establishment of a fully integrated statistics and data management function and the implementation of Oracle Clinical. Prior to that, Collard worked for Bayer plc, Wyeth Research UK and a large, international clinical research organization. In all, she possesses more than two decades of management experience, statistical knowledge and clinical data operations expertise.
Collard holds a bachelor of science degree (Hons, 2.1) in statistics from the University of Bath and is a Chartered Statistician and Member of PSI - Statisticians in the Pharmaceutical Industry. In 2002 she was awarded Honorary Membership of the Association for Clinical Data Management, having served previously as its Secretary and Treasurer.
Kendle Biometrics provides clinical data management and biostatistical services to ensure consistent delivery of high quality data, reduce costs and expedite the clinical development process. This is accomplished by applying targeted data cleaning strategies and partnering with our customers to optimize the outcome of clinical studies.
About Kendle International Inc.
Kendle International Inc. is among the world’s leading global clinical research organizations. We deliver innovative and robust clinical development solutions - from first-in-man studies through market launch and surveillance - to help the world’s biopharmaceutical companies maximize product life cycles and grow market share. With headquarters in Cincinnati and more than 1,700 associates worldwide, Kendle has conducted clinical trials or provided regulatory and validation services in more than 60 countries. Investor kits are available upon request from Kendle International Inc., 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or from the company’s Web site at http://www.kendle.com/ .
Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Investors, Buzz Brenkert, +1-513-345-1525, or Media, LoriDorer, +1-513-345-1685, both of Kendle International Inc.
Web site: http://www.kendle.com/